Skip to main content

MediaCenter Panda Security

MediaCenter Panda Security


Buying smartwatches – The latest craze that’s also a security risk

Posted: 14 Aug 2015 02:15 AM PDT

smartwatches

This is the latest must-have in mobile devices and the more its popularity increases, the more our confidential information is at risk – as they become more popular, smartwatches are now becoming the latest target for cybercriminals.

At the end of the day, millions of users will store their personal data on these devices that act as a bridge with our mobile phones. Therefore, the security of wearable fashion should be a matter of vital importance for manufacturers.

However, the current proliferation of smartwatches ​​is far from being as secure as we would expect from a device that is setting out to become popular worldwide.

According to a recent study carried out by HP, the majority of smartwatches that are currently available are at risk of cybernetic attacks.

Further proof of this is shown in the recent smartwatch that was unveiled by Apple. At the moment, there is nothing to prevent the password of the Apple Watch from being deleted and a stolen device being used to make purchases.

However, Apple is not the only manufacturer of smartwatches that needs to improve the security of its wearable products. In fact, the details of the study are telling – 100% of the analyzed models have a vulnerability that threatens user data. The main weak point is the absence of a double authentication process which, undoubtedly, would make the product more secure.

In addition, researchers found unsafe web interfaces and outdated methods of data encryption on the devices. To make matters worse, 70% of the watches analyzed have problems with their firmware updates.

smartwatch

Beyond the risk to the information gathered by the smartwatches (passwords, bank details and even the heartbeat of its owner), the vulnerabilities of these devices could be used by cybercriminals to access networks and computers connected to the smartwatch. That means that the security of these watches may impact the rest of our technological lives.

"It is vital that we take precautions when sending confidential information or when we wear smartwatches to work", explained the people behind the study.

For now, there is little that users can do to make their smartwatch completely secure. Therefore, it is best to check which model offers more tools to protect your information and, above all, take special caution when sharing confidential information with your wearable devices.

The post Buying smartwatches – The latest craze that's also a security risk appeared first on MediaCenter Panda Security.

Comments

Popular posts from this blog

The first drug for a common, deadly liver disease is here – and more are coming

VIEW IN BROWSER | SUBSCRIBE TUE, MAR 19, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good morning!  Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for the condition.    In a landmark decision on Thursday, the Food and Drug Administration approved Madrigal Pharmaceuticals ' drug " Rezdiffra ," to be used along with diet and exercise. The company expects the medicine to be available next month with a hefty price tag of $47,400 per year before insurance and other rebates.    So, why is this approval so important?    First of all, people suffering from the disease badly need a treatment. Rezdiffra is specifically approved to treat patients with nonalcoholic steatoh

J&J, Merck and Bristol Myers Squibb are in the hot seat

VIEW IN BROWSER | SUBSCRIBE TUE, JAN 30, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com .    Three names in the industry – Johnson & Johnson, Merck and Bristol Myers Squibb – face a pivotal few weeks ahead.    CEOs from those companies are slated to testify at a Senate hearing on high prescription drug prices in the U.S. on Feb. 8 at 10 a.m. ET, Sen. Bernie Sanders announced Friday.   It took subpoena threats from the senator, but J&J CEO Joaquin Duato and Merck CEO Robert Davis have agreed to testify after both executives declined earlier requests to appear at the Senate HELP committee's hearing. They join Bristol Myers Squibb CEO Chris Boerner, who agr

Israel activates evacuation plan for 28 communities along Lebanon border

To keep you updated, we send Defence News to your mailbox. In case, you wish to Unsubscribe Click Here Defence News Dear Reader, Just catching up? Here are the top